The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

Rhodamine 123     [6-amino-9-(2- methoxycarbonylphenyl) xanthe...

Synonyms: Rhodamine-123, CHEBI:8828, LS-162564, RH 123, AKOS015917525, ...
This record was replaced with 65218.
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Rhodamine 123

 

High impact information on Rhodamine 123

  • Rh123 and several other fluorescent dyes are substrates for transport mediated by P-glycoprotein (P-gp), an efflux pump responsible for multidrug resistance in tumor cells [6].
  • Rhodamine-123, a cationic laser dye, markedly reduced the clonal growth of carcinoma cells but had little effect on nontumorigenic epithelial cells in vitro [7].
  • Finally, we demonstrated that the Endo(Pos) Sca-1(Pos) Rh(Low) (Rhodamine-123 low) phenotype, without using CD34, c-Kit, or Lineage markers, defines a nearly homogenous population of LTR-HSCs [8].
  • Both Rh123 fractions proliferated in response to MGF alone as determined by a [3H]TdR assay or by counting nucleated cells present in the cultures over time [9].
  • Stimulation of both Rh123 fractions with MGF alone did not result in a net increase of day 14 CFU-S [9].
 

Chemical compound and disease context of Rhodamine 123

 

Biological context of Rhodamine 123

 

Anatomical context of Rhodamine 123

 

Associations of Rhodamine 123 with other chemical compounds

 

Gene context of Rhodamine 123

  • Flow cytometric analysis of MDR1 expression (D) and function (rhodamine-123 efflux) was obtained in 203 and 158 patients, respectively [29].
  • In a nonhematological model, the P-gp expressing HCT-8 adenocarcinoma cell line, exogenously added IL-2 was shown to exert an inhibitory effect on P-gp mediated Rhodamine-123 efflux [23].
  • In contrast to R123, a 60 min DNR or calcein-AM accumulation test could be used to detect MRP-mediated resistance [30].
  • MATERIALS AND METHODS: Extremely primitive Bcr-Abl fusion positive cells were purified from patients with CML using multiparameter flow cytometric analysis of CD34, Thy, and lineage marker (Lin) expression, plus rhodamine-123 (Rh-123) brightness [31].
  • Uptake studies in the presence and absence of rhodamine 123 (R123; 3.2 and 5.0 microM) were also performed in a Pgp overexpressing cell line, MCF-7/Adr [32].
 

Analytical, diagnostic and therapeutic context of Rhodamine 123

  • Rhodamine 123 (Rh123) staining and flow cytometry analysis showed a significantly decreased mean fluorescence in 51 C219+ and 38 JSB1+ patients compared to 42 MDR negative ones (P < .001) [33].
  • The techniques discussed include classic imaging techniques, such as rhodamine-123, the highly advanced semi-conductor nanoparticles (quantum dots), and wide field microscopy as well as high-resolution multiphoton imaging [34].
  • Immunofluorescence experiments suggest that T cells from old and young mice have equal amounts of the P-Gp molecule itself, suggesting that differences in R123 extrusion may depend on posttranslational regulation of P-Gp activity [35].
  • After direct microinjection of R123 into the vacuole in which the parasite grows and multiples, the dye appeared in the host-cell mitochondria but not in the parasite's mitochondria [36].
  • A low Rh123 accumulation and a high Rh123 efflux blocking by PSC833 were associated with a low complete remission (CR) rate after the first cycle of chemotherapy (P = 0.008 and P = 0.01, respectively) [37].

References

  1. Cationic drug analysis using matrix-assisted laser desorption/ionization mass spectrometry: application to influx kinetics, multidrug resistance, and intracellular chemical change. Rideout, D., Bustamante, A., Siuzdak, G. Proc. Natl. Acad. Sci. U.S.A. (1993) [Pubmed]
  2. Multidrug resistance in acute leukemia: a comparison of different diagnostic methods. Pall, G., Spitaler, M., Hofmann, J., Thaler, J., Ludescher, C. Leukemia (1997) [Pubmed]
  3. Hypothyroidism prevents postnatal changes in rat liver mitochondrial populations defined by rhodamine-123 staining. Almeida, A., Orfao, A., López-Mediavilla, C., Medina, J.M. Endocrinology (1995) [Pubmed]
  4. Effect of endotoxin on P-glycoprotein-mediated biliary and renal excretion of rhodamine-123 in rats. Ando, H., Nishio, Y., Ito, K., Nakao, A., Wang, L., Zhao, Y.L., Kitaichi, K., Takagi, K., Hasegawa, T. Antimicrob. Agents Chemother. (2001) [Pubmed]
  5. Effect of ischemia-reperfusion injury on the microcirculation of the steatotic liver of the Zucker rat. Sun, C.K., Zhang, X.Y., Zimmermann, A., Davis, G., Wheatley, A.M. Transplantation (2001) [Pubmed]
  6. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Chaudhary, P.M., Roninson, I.B. Cell (1991) [Pubmed]
  7. Rhodamine-123 selectively reduces clonal growth of carcinoma cells in vitro. Bernal, S.D., Lampidis, T.J., Summerhayes, I.C., Chen, L.B. Science (1982) [Pubmed]
  8. The endoglin(positive) sca-1(positive) rhodamine(low) phenotype defines a near-homogeneous population of long-term repopulating hematopoietic stem cells. Chen, C.Z., Li, L., Li, M., Lodish, H.F. Immunity (2003) [Pubmed]
  9. The effect of recombinant mast cell growth factor on purified murine hematopoietic stem cells. de Vries, P., Brasel, K.A., Eisenman, J.R., Alpert, A.R., Williams, D.E. J. Exp. Med. (1991) [Pubmed]
  10. Ultrasound-Induced hyperthermia increases cellular uptake and cytotoxicity of P-glycoprotein substrates in multi-drug resistant cells. Liu, Y., Cho, C.W., Yan, X., Henthorn, T.K., Lillehei, K.O., Cobb, W.N., Ng, K.Y. Pharm. Res. (2001) [Pubmed]
  11. Targeting calmodulin for the development of novel cancer chemotherapeutic agents. Hait, W.N. Anticancer Drug Des. (1987) [Pubmed]
  12. Overcoming MDR by ultrasound-induced hyperthermia and P-glycoprotein modulation. Liu, Y., Lillehei, K., Cobb, W.N., Christians, U., Ng, K.Y. Biochem. Biophys. Res. Commun. (2001) [Pubmed]
  13. Photophysical, photochemical, and tumor-selectivity properties of bromine derivatives of rhodamine-123. Lacerda, S.H., Abraham, B., Stringfellow, T.C., Indig, G.L. Photochem. Photobiol. (2005) [Pubmed]
  14. Comparison between anthracyclines and rhodamine-123 accumulation in chronic lymphoid leukemia: effect of cyclosporin A and verapamil. Maia, R.C., Vasconcelos, F.C., Harab, R.C., Coelho, A.M., Dobbin, J.A., Rumjanek, V.M. Tumour Biol. (1998) [Pubmed]
  15. Stem cell factor induces proliferation and differentiation of highly enriched murine hematopoietic cells. Migliaccio, G., Migliaccio, A.R., Valinsky, J., Langley, K., Zsebo, K., Visser, J.W., Adamson, J.W. Proc. Natl. Acad. Sci. U.S.A. (1991) [Pubmed]
  16. Effect of the protein kinase C inhibitor staurosporine on chemosensitivity to daunorubicin of normal and leukemic fresh myeloid cells. Laredo, J., Huynh, A., Muller, C., Jaffrézou, J.P., Bailly, J.D., Cassar, G., Laurent, G., Demur, C. Blood (1994) [Pubmed]
  17. Uncouplers of oxidative phosphorylation can enhance a Fas death signal. Linsinger, G., Wilhelm, S., Wagner, H., Häcker, G. Mol. Cell. Biol. (1999) [Pubmed]
  18. Quantitative assessment of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells engrafted in nonobese diabetic/severe combined immunodeficient mice. Schiedlmeier, B., Kühlcke, K., Eckert, H.G., Baum, C., Zeller, W.J., Fruehauf, S. Blood (2000) [Pubmed]
  19. Rhodamine-123 staining in hematopoietic stem cells of young mice indicates mitochondrial activation rather than dye efflux. Kim, M., Cooper, D.D., Hayes, S.F., Spangrude, G.J. Blood (1998) [Pubmed]
  20. Lactic dehydrogenase isozymes, 31P magnetic resonance spectroscopy, and in vitro antimitochondrial tumor toxicity with gossypol and rhodamine-123. Benz, C., Hollander, C., Keniry, M., James, T.L., Mitchell, M. J. Clin. Invest. (1987) [Pubmed]
  21. Cellular uptake and intracellular localization of benzo(a)pyrene by digital fluorescence imaging microscopy. Plant, A.L., Benson, D.M., Smith, L.C. J. Cell Biol. (1985) [Pubmed]
  22. Protein kinase Cdelta targets mitochondria, alters mitochondrial membrane potential, and induces apoptosis in normal and neoplastic keratinocytes when overexpressed by an adenoviral vector. Li, L., Lorenzo, P.S., Bogi, K., Blumberg, P.M., Yuspa, S.H. Mol. Cell. Biol. (1999) [Pubmed]
  23. Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes. Drach, J., Gsur, A., Hamilton, G., Zhao, S., Angerler, J., Fiegl, M., Zojer, N., Raderer, M., Haberl, I., Andreeff, M., Huber, H. Blood (1996) [Pubmed]
  24. Stable multilineage hematopoietic chimerism in alpha-thalassemic mice induced by a bone marrow subpopulation that excludes the majority of day-12 spleen colony-forming units. van der Loo, J.C., van den Bos, C., Baert, M.R., Wagemaker, G., Ploemacher, R.E. Blood (1994) [Pubmed]
  25. ABC transporter activities of murine hematopoietic stem cells vary according to their developmental and activation status. Uchida, N., Dykstra, B., Lyons, K., Leung, F., Kristiansen, M., Eaves, C. Blood (2004) [Pubmed]
  26. Phenotypic heterogeneity of primitive leukemic hematopoietic cells in patients with chronic myeloid leukemia. Udomsakdi, C., Eaves, C.J., Lansdorp, P.M., Eaves, A.C. Blood (1992) [Pubmed]
  27. Prevalence of multidrug resistance related to activation of the mdr1 gene in human sarcoma mutants derived by single-step doxorubicin selection. Chen, G., Jaffrézou, J.P., Fleming, W.H., Durán, G.E., Sikic, B.I. Cancer Res. (1994) [Pubmed]
  28. Nitric oxide mediates lipopolysaccharide-induced alteration of mitochondrial function in cultured hepatocytes and isolated perfused liver. Kurose, I., Kato, S., Ishii, H., Fukumura, D., Miura, S., Suematsu, M., Tsuchiya, M. Hepatology (1993) [Pubmed]
  29. MDR1 protein expression is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia. Tafuri, A., Gregorj, C., Petrucci, M.T., Ricciardi, M.R., Mancini, M., Cimino, G., Mecucci, C., Tedeschi, A., Fioritoni, G., Ferrara, F., Di Raimondo, F., Gallo, E., Liso, V., Fabbiano, F., Cascavilla, N., Pizzolo, G., Camera, A., Pane, F., Lanza, F., Cilloni, D., Annino, L., Vitale, A., Vegna, M.L., Vignetti, M., Foà, R., Mandelli, F. Blood (2002) [Pubmed]
  30. Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometry. Feller, N., Kuiper, C.M., Lankelma, J., Ruhdal, J.K., Scheper, R.J., Pinedo, H.M., Broxterman, H.J. Br. J. Cancer (1995) [Pubmed]
  31. The effect of Bcr-Abl protein tyrosine kinase on maturation and proliferation of primitive haematopoietic cells. Buckle, A.M., Mottram, R., Pierce, A., Lucas, G.S., Russell, N., Miyan, J.A., Whetton, A.D. Mol. Med. (2000) [Pubmed]
  32. Influence of multidrug resistance (MDR) proteins at the blood-brain barrier on the transport and brain distribution of enaminone anticonvulsants. Cox, D.S., Scott, K.R., Gao, H., Raje, S., Eddington, N.D. Journal of pharmaceutical sciences. (2001) [Pubmed]
  33. Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia. Del Poeta, G., Stasi, R., Aronica, G., Venditti, A., Cox, M.C., Bruno, A., Buccisano, F., Masi, M., Tribalto, M., Amadori, S., Papa, G. Blood (1996) [Pubmed]
  34. Optical and pharmacological tools to investigate the role of mitochondria during oxidative stress and neurodegeneration. Foster, K.A., Galeffi, F., Gerich, F.J., Turner, D.A., Müller, M. Prog. Neurobiol. (2006) [Pubmed]
  35. Increased function of P-glycoprotein in T lymphocyte subsets of aging mice. Witkowski, J.M., Miller, R.A. J. Immunol. (1993) [Pubmed]
  36. Reduction in the mitochondrial membrane potential of Toxoplasma gondii after invasion of host cells. Tanabe, K., Murakami, K. J. Cell. Sci. (1984) [Pubmed]
  37. P-glycoprotein and multidrug resistance protein activities in relation to treatment outcome in acute myeloid leukemia. van der Kolk, D.M., de Vries, E.G., van Putten, W.J., Verdonck, L.F., Ossenkoppele, G.J., Verhoef, G.E., Vellenga, E. Clin. Cancer Res. (2000) [Pubmed]
 
WikiGenes - Universities